Clinical and Experimental Reproductive Medicine

  • 제47권2호
  • /
  • Pages.130-134
  • /
  • 2020
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지
DOI QR코드

DOI QR Code

The effect of insemination methods on in vitro maturation outcomes

  • 투고 : 2019.09.01
  • 심사 : 2019.10.18
  • 발행 : 2020.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: The aim of this study was to compare the effects of conventional insemination (in vitro fertilization [IVF]) and intracytoplasmic sperm injection (ICSI) on the fertilization, developmental competence, implantation potential, and clinical pregnancy rate of embryos derived from in vitro matured oocytes of patients with polycystic ovary syndrome (PCOS). Methods: A prospective study was carried out among 38 PCOS patients who had undergone In vitro maturation (IVM) treatment. In total, 828 immature oocytes were collected from 42 cycles and randomly assigned for insemination by IVF (416 oocytes) or ICSI (412 oocytes). After fertilization, the embryos were cultured until the blastocyst stage and single embryos were transferred after endometrial preparation and under ultrasound guidance. Results: No significant differences were found in the maturation rate (78.1% vs. 72.6% for IVF and ICSI insemination, respectively; p= 0.076), fertilization rate (59.4% vs. 66.9% for IVF and ICSI insemination, respectively; p= 0.063), or the formation of good-quality blastocysts (40.9% vs. 46.5% for IVF and ICSI insemination, respectively; p= 0.314). Implantation and clinical pregnancy also did not show significant differences. Conclusion: There was a comparable yield of in vitro matured oocytes derived from PCOS patients in terms of fertilization, blastocyst formation, implantation rate, and clinical pregnancy between IVF and ICSI insemination. These findings provide valuable insights for choosing assisted reproductive treatment in women with PCOS, as IVM offers promising outcomes and is less invasive and less costly.

키워드

참고문헌

  1. Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod 2012;27:3601-8. https://doi.org/10.1093/humrep/des359
  2. Julania S, Walls ML, Hart R. The place of in vitro maturation in PCO/PCOS. Int J Endocrinol 2018;2018:5750298. https://doi.org/10.1155/2018/5750298
  3. Hwang JL, Lin YH, Tsai YL. In vitro maturation and fertilization of immature oocytes: a comparative study of fertilization techniques. J Assist Reprod Genet 2000;17:39-43. https://doi.org/10.1023/A:1009450014064
  4. Walls M, Junk S, Ryan JP, Hart R. IVF versus ICSI for the fertilization of in-vitro matured human oocytes. Reprod Biomed Online 2012;25:603-7. https://doi.org/10.1016/j.rbmo.2012.08.001
  5. Dietzel E, Wessling J, Floehr J, Schafer C, Ensslen S, Denecke B, et al. Fetuin-B, a liver-derived plasma protein is essential for fertilization. Dev Cell 2013;25:106-12. https://doi.org/10.1016/j.devcel.2013.03.001
  6. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva:WHO Press; 2010.
  7. Junk SM, Yeap D. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome. Fertil Steril 2012;98:888-92. https://doi.org/10.1016/j.fertnstert.2012.06.055
  8. Soderstrom-Anttila V, Makinen S, Tuuri T, Suikkari AM. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod 2005;20:1534-40. https://doi.org/10.1093/humrep/deh768
  9. Pongsuthirak P, Songveeratham S, Vutyavanich T. Comparison of blastocyst and Sage media for in vitro maturation of human immature oocytes. Reprod Sci 2015;22:343-6. https://doi.org/10.1177/1933719114542027
  10. Zhang XY, Ata B, Son WY, Buckett W, Tan SL, Ao A. The chromosome constitution of IVM embryos generated from oocytes at different maturation interval. Fertil Steril 2010;94;S142-3.
  11. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y, Tanaka T. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod 1995;10:1962-7. https://doi.org/10.1093/oxfordjournals.humrep.a136217
  12. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:1337-44. https://doi.org/10.1210/jcem.87.3.8316
  13. Kahyaoglu I, Demir B, Turkkani A, Cinar O, Dilbaz S, Dilbaz B, et al. Total fertilization failure: is it the end of the story? J Assist Reprod Genet 2014;31:1155-60. https://doi.org/10.1007/s10815-014-0281-5
  14. Simopoulou M, Giannelou P, Bakas P, Gkoles L, Kalampokas T, Pantos K, et al. Making ICSI safer and more effective: a review of the human oocyte and ICSI practice. In Vivo 2016;30:387-400.
  15. Hyun CS, Cha JH, Son WY, Yoon SH, Kim KA, Lim JH. Optimal ICSI timing after the first polar body extrusion in in vitro matured human oocytes. Hum Reprod 2007;22:1991-5. https://doi.org/10.1093/humrep/dem124